Targeted drug found to combat certain pancreatic tumours
Researchers have found that the CDK inhibitor AT7519 could be…
Researchers have found that the CDK inhibitor AT7519 could be used to treat pancreatic cancer patients whose tumours are addicted to mutant KRAS.